Cipla 2011
Posted: 1 Mar 2012
Date Written: April 12, 2011
Abstract
Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.
Learning Objective: Examine how a leader's moral commitments inform and shape the strategic decisions he takes.
Suggested Citation: Suggested Citation
Deshpande, Rohit and Sucher, Sandra J. and Winig, Laura, Cipla 2011 (April 12, 2011). Harvard Business School Marketing Unit Case No. 511-050, Available at SSRN: https://ssrn.com/abstract=2013232
Sandra J. Sucher
Harvard University - Business School (HBS) ( email )
Soldiers Field Road
Morgan 479
Boston, MA 02163
United States
Laura Winig
Harvard Business School, Global Research Group ( email )
Greenhill House
Soldiers Field
Boston, MA 02163
United States
Feedback
Feedback to SSRN